WORLD
From Breakingviews: CureVac S Value Halved to $10 Billion After It Said Its COVID-19 ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'From @Breakingviews: CureVac’s value halved to $10 billion after it said its COVID-19 vaccine may be only 47% effective. Separate trials on its cancer vaccine will be key to the German drugmaker’s future health, writes @aimeedonnellan ...'
From @Breakingviews: CureVac’s value halved to $10 billion after it said its COVID-19 vaccine may be only 47% effective. Separate trials on its cancer vaccine will be key to the German drugmaker’s future health, writes @aimeedonnellan https://t.co/8WTUihx9bV— Reuters (@Reuters) June 17, 2021
(The above story first appeared on LatestLY on Jun 17, 2021 10:50 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
